image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 6 days, don't miss out!

Plus500

October 2026

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PLUS
  • Price:
  • 3696p
The shares incredibly went over £50 (gain-to-high more than double my November ‘24 write-up) before a pull-back. Interims came in strong  with revenues up 12% year-on-year to US$463m while “customer income” - gross revenue from client trading - expanded 24% to a five-year record of US$460.8m as it shrugged off temporary drags from customer trading performance and lower interest rates. Despite stepped-up marketing investments, international expansion costs, and foreign exchange headwinds, Plus500 sustained an EBITDA margin of 41%, generating US$187.5m in EBITDA.  The group’s strategic pivot away from purely OTC CFDs toward a multi-asset fintech platform is delivering tangible results. Non-OTC revenue grew 30% year-on-year, n ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe